Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy
Main Author: | Lianbo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.971477/full |
Similar Items
-
Advances in Hypoxia Microenvironment and Chemotherapy-resistant
of Lung Cancer
by: Yang GUO, et al.
Published: (2014-03-01) -
Post-chemotherapy arthralgia and arthritis in lung cancer
by: Aref H Amiri, et al.
Published: (2012-01-01) -
Ku80 correlates with neoadjuvant chemotherapy resistance in human lung adenocarcinoma, but reduces cisplatin/pemetrexed-induced apoptosis in A549 cells
by: Bin Shang, et al.
Published: (2017-04-01) -
Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
by: Cecilie Abildgaard, et al.
Published: (2020-01-01) -
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
by: Gabriela Rodríguez-Macías, et al.
Published: (2023-06-01)